ACETAZOLAMIDE EXTENDED-RELEASE
NDC 42571-243, Acetazolamide extended-release, capsule, from Micro Labs Limited.
- Product NDC
- 42571-243
- Status
- Listed
- Labeler
- Micro Labs Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207401
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42571-243 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAZOLAMIDE500 mg/1
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42571-243-01 | 42571024301 | 100 CAPSULE in 1 BOTTLE (42571-243-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/78f78919-a6ba-4072-bc45-2ab3637ed894NADAC price for package 42571024301
GET /v1/drugs/nadac/42571024301
Use it
Look up 42571-243 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42571-243 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42571-243. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.